Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Vickery

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Mental Health Clinician|June 30, 2018
Early detection of an atypical presentation of neuroleptic malignant syndrome: A case reportP Brittany Vickery, Lindsy Meadowcraft, Stephen B Vickery
The Senior Care Pharmacist|July 29, 2020
Incorporating Pharmacist Interns Into a Study of Fall-RisksP Brittany Vickery, Greg Ginn, Stephen B Vickery
Pharmacotherapy|August 14, 2016
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosaStephen B Vickery, David McClain, Kurt A Wargo
The Mental Health Clinician|July 8, 2022
Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapineStephen B Vickery, Andrew D Burch, P Brittany Vickery
Pharmacotherapy|March 7, 2012
Boceprevir: a novel NS3/4 protease inhibitor for the treatment of hepatitis COlga M Klibanov, Stephen B Vickery, Jacqueline L Olin, et al.
Pharmacotherapy|September 29, 2011
Telaprevir: a novel NS3/4 protease inhibitor for the treatment of hepatitis COlga M Klibanov, Shannon H Williams, Lisa S Smith, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Mental Health Clinician|June 30, 2018
Early detection of an atypical presentation of neuroleptic malignant syndrome: A case reportP Brittany Vickery, Lindsy Meadowcraft, Stephen B Vickery
The Senior Care Pharmacist|July 29, 2020
Incorporating Pharmacist Interns Into a Study of Fall-RisksP Brittany Vickery, Greg Ginn, Stephen B Vickery
Pharmacotherapy|August 14, 2016
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosaStephen B Vickery, David McClain, Kurt A Wargo
The Mental Health Clinician|July 8, 2022
Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapineStephen B Vickery, Andrew D Burch, P Brittany Vickery
Pharmacotherapy|March 7, 2012
Boceprevir: a novel NS3/4 protease inhibitor for the treatment of hepatitis COlga M Klibanov, Stephen B Vickery, Jacqueline L Olin, et al.
Pharmacotherapy|September 29, 2011
Telaprevir: a novel NS3/4 protease inhibitor for the treatment of hepatitis COlga M Klibanov, Shannon H Williams, Lisa S Smith, et al.
Pageof 1